Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey
- 1 January 1991
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 44 (3) , 591-605
- https://doi.org/10.1016/0306-4522(91)90080-8
Abstract
No abstract availableThis publication has 84 references indexed in Scilit:
- Reversal of Experimental Parkinsonism by Lesions of the Subthalamic NucleusScience, 1990
- Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTPBrain Research, 1987
- MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal areaNeuropharmacology, 1986
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- The Clinical Syndrome of Striatal Dopamine DeficiencyNew England Journal of Medicine, 1985
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- A Direct Role of Dopamine in the Rat Subthalamic Nucleus and an Adjacent Intrapeduncular AreaScience, 1979
- Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis ratesBrain Research, 1979
- Regional distribution of catecholamines in monkey cerebral cortex, evidence for a dopaminergic innervation of the primate prefrontal cortexNeuroscience Letters, 1978
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973